Albemarle Corp's income statement, balance sheet and cash flow statement as filed with the SEC (10-K and 10-Q), with the latest fiscal years and quarters. In its latest fiscal year (Dec 31, 2025 · FY), Albemarle Corp reported revenue of $5.1B (-4.4% year on year).
| Line item | Dec 31, 2025 · FY | Dec 31, 2024 · FY | Dec 31, 2023 · FY | Dec 31, 2022 · FY |
|---|---|---|---|---|
| Revenues | $5.1B | $5.4B | $9.6B | $7.3B |
| Cost of goods sold | $4.5B | $5.3B | $8.4B | $4.2B |
| Gross profit | $668.7M | $62.5M | $1.2B | $3.1B |
| Selling, general and administrative expenses | $550.0M | $618.0M | $919.5M | $524.1M |
| Goodwill impairment | $181.1M | — | — | — |
| Long-lived asset impairment charges | $245.6M | — | — | — |
| Restructuring charges and asset write-offs | $7.7M | $1.1B | — | — |
| Research and development expenses | $51.4M | $86.7M | $85.7M | $72.0M |
| Gain on change in interest in properties/sale of business, net | $0 | $0 | ($71.2M) | $8.4M |
| Operating (loss) profit | ($367.1M) | ($1.8B) | $251.9M | $2.5B |
| Interest and financing expenses | ($207.7M) | ($165.6M) | ($116.1M) | ($123.0M) |
| Other income, net | $22.7M | $178.3M | $110.9M | $86.4M |
| (Loss) income before income taxes and equity in net income of unconsolidated investments | ($552.1M) | ($1.8B) | $246.7M | $2.4B |
| Income tax expense | $156.9M | $87.1M | $430.3M | $390.6M |
| Loss before equity in net income of unconsolidated investments | ($709.0M) | — | — | — |
| Equity in net income of unconsolidated investments (net of tax) | $243.7M | $715.4M | $1.9B | $772.3M |
| Net (loss) income | ($465.2M) | ($1.1B) | $1.7B | $2.8B |
| Net income attributable to noncontrolling interests | ($45.4M) | ($44.0M) | ($97.1M) | ($125.3M) |
| Net (loss) income attributable to Albemarle Corporation | ($510.6M) | ($1.2B) | $1.6B | $2.7B |
| Mandatory convertible preferred stock dividends | ($166.8M) | ($136.6M) | — | — |
| Net (loss) income attributable to Albemarle Corporation common shareholders, basic | ($677.4M) | ($1.3B) | — | — |
| Net (loss) income attributable to Albemarle Corporation common shareholders, diluted | ($677.4M) | ($1.3B) | — | — |
| Basic earnings (loss) per share attributable to common shareholders (in dollars per share) | -$5.76 | -$11.20 | $13.41 | $22.97 |
| Diluted earnings (loss) per share attributable to common shareholders (in dollars per share) | -$5.76 | -$11.20 | $13.36 | $22.84 |
| Weighted-average common shares outstanding—basic (in shares) | 117.7M | 117.5M | 117.3M | 117.1M |
| Weighted-average common shares outstanding—diluted (in shares) | 117.7M | 117.5M | 117.8M | 117.8M |
| Line item | Jun 30, 2026 · Q2 | Mar 31, 2026 · Q1 | Sep 30, 2025 · Q3 | Jun 30, 2025 · Q2 |
|---|---|---|---|---|
| Net sales | $1.7B | $1.4B | $1.3B | $1.3B |
| Cost of goods sold | $1.2B | $927.8M | $1.2B | $1.1B |
| Gross profit | $590.3M | $501.0M | $117.6M | $196.9M |
| Selling, general and administrative expenses | $126.4M | $137.4M | $138.6M | $132.5M |
| Restructuring charges and asset write-offs | $7.3M | $25.9M | $2.3M | $4.4M |
| Research and development expenses | $3.7M | $9.2M | $12.7M | $12.4M |
| Loss on sale of business | $0 | $95.0M | — | — |
| Operating profit | $452.9M | $233.5M | ($217.0M) | $47.5M |
| Interest and financing expenses | ($30.9M) | ($33.1M) | ($51.0M) | ($49.9M) |
| Other income (expenses), net | $19.6M | $53.8M | $28.8M | ($6.6M) |
| Income (loss) before income taxes and equity in net income of unconsolidated investments | $441.6M | $254.2M | ($239.1M) | ($9.0M) |
| Income tax expense | $94.0M | $21.5M | ($30.6M) | $34.1M |
| Income (loss) before equity in net income of unconsolidated investments | $347.6M | $232.7M | ($208.6M) | ($43.1M) |
| Equity in net income of unconsolidated investments (net of tax) | $151.6M | $96.3M | $60.6M | $78.3M |
| Net income | $499.2M | $329.0M | ($147.9M) | $35.2M |
| Net income attributable to noncontrolling interests | ($19.3M) | ($9.9M) | ($12.8M) | ($12.3M) |
| Net income attributable to Albemarle Corporation | $480.0M | $319.1M | ($160.7M) | $22.9M |
| Mandatory convertible preferred stock dividends | ($41.7M) | ($41.7M) | ($41.7M) | ($41.7M) |
| Net income (loss) attributable to Albemarle Corporation common shareholders | $438.3M | $277.4M | ($202.4M) | ($18.8M) |
| Basic earnings (loss) per share attributable to common shareholders (in dollars per share) | $3.72 | $2.35 | -$1.72 | -$0.16 |
| Diluted earnings (loss) per share attributable to common shareholders (in dollars per share) | $3.52 | $2.34 | -$1.72 | -$0.16 |
| Weighted-average common shares outstanding - basic (in shares) | 118.0M | 117.9M | 117.7M | 117.7M |
| Weighted-average common shares outstanding - diluted (in shares) | 136.2M | 118.6M | 117.7M | 117.7M |
| Line item | Dec 31, 2025 · FY | Dec 31, 2024 · FY | Dec 31, 2023 · FY | Dec 31, 2022 · FY |
|---|---|---|---|---|
| Cash and cash equivalents | $1.6B | $1.2B | $889.9M | $1.5B |
| Trade accounts receivable, less allowance for credit losses (2025—$4,578; 2024—$5,201) | $593.5M | $742.2M | $1.2B | $1.2B |
| Other accounts receivable | $105.1M | $238.4M | $509.1M | $185.8M |
| Inventories | $1.2B | $1.5B | $2.2B | $2.1B |
| Other current assets | $140.4M | $166.9M | $443.5M | $235.0M |
| Current assets held for sale | $371.8M | — | — | — |
| Total current assets | $4.0B | $3.8B | $5.2B | $5.2B |
| Property, plant and equipment, at cost | $11.8B | $12.5B | $12.2B | $9.4B |
| Less accumulated depreciation and amortization | $3.2B | $3.2B | $2.7B | $2.4B |
| Net property, plant and equipment | $8.6B | $9.3B | $9.5B | $7.0B |
| Investments | $900.9M | $1.1B | $1.4B | $1.2B |
| Other assets | $647.2M | $504.7M | $297.1M | $250.6M |
| Goodwill | $1.5B | $1.6B | $1.6B | $1.6B |
| Other intangibles, net of amortization | $214.2M | $230.8M | $261.9M | $287.9M |
| Noncurrent assets held for sale | $491.7M | — | — | — |
| Total assets | $16.4B | $16.6B | $18.3B | $15.5B |
| Accounts payable | $913.5M | $943.9M | $2.1B | $1.5B |
| Accrued expenses | $521.8M | $468.0M | $544.8M | $505.9M |
| Current portion of long-term debt | $74.1M | $398.0M | $625.8M | $2.1M |
| Dividends payable | $61.4M | $61.3M | $46.7M | $46.1M |
| Income taxes payable | $35.5M | $95.3M | $255.2M | $134.9M |
| Current liabilities held for sale | $191.8M | — | — | — |
| Total current liabilities | $1.8B | $2.0B | $3.6B | $2.7B |
| Long-term debt | $3.1B | $3.1B | $3.5B | $3.2B |
| Postretirement benefits | $44.7M | $31.9M | $26.2M | $32.8M |
| Pension benefits | $117.4M | $116.2M | $150.3M | $159.6M |
| Other noncurrent liabilities | $1.1B | $819.2M | $769.1M | $636.6M |
| Deferred income taxes | $368.3M | $358.0M | $558.4M | $480.8M |
| Noncurrent liabilities held for sale | $60.0M | — | — | — |
| Common stock, $.01 par value (authorized 275,000 shares), issued and outstanding — 117,716 in 2025 and 117,560 in 2024 | 1.2M | 1.2M | 1.2M | 1.2M |
| Mandatory convertible preferred stock, Series A, no par value, $1,000 stated value, authorized - 15,000, issued and outstanding - 2,300 in 2025 and 2024 | $2.2B | $2.2B | — | — |
| Additional paid-in capital | $3.0B | $3.0B | $3.0B | $2.9B |
| Accumulated other comprehensive loss | ($334.8M) | ($742.1M) | ($528.5M) | ($560.7M) |
| Retained earnings | $4.6B | $5.5B | $7.0B | $5.6B |
| Total Albemarle Corporation shareholders’ equity | $9.5B | $10.0B | $9.4B | $8.0B |
| Noncontrolling interests | $248.1M | $238.2M | $252.9M | $208.2M |
| Total equity | $9.8B | $10.2B | $9.7B | $8.2B |
| Total liabilities and equity | $16.4B | $16.6B | $18.3B | $15.5B |
| Line item | Jun 30, 2026 | Mar 31, 2026 | Sep 30, 2025 | Jun 30, 2025 |
|---|---|---|---|---|
| Cash and cash equivalents | $1.6B | $1.1B | $1.9B | $1.8B |
| Trade accounts receivable, less allowance for credit losses (2026 – $4,582; 2025 – $4,578) | $603.8M | $522.7M | $733.5M | $766.4M |
| Other accounts receivable | $123.9M | $136.8M | $107.7M | $113.3M |
| Inventories | $1.4B | $1.3B | $1.5B | $1.6B |
| Other current assets | $200.3M | $162.9M | $249.3M | $177.7M |
| Current assets held for sale | $0 | $0 | — | — |
| Total current assets | $3.9B | $3.3B | $4.6B | $4.5B |
| Property, plant and equipment, at cost | $11.9B | $11.8B | $12.9B | $12.8B |
| Less accumulated depreciation and amortization | $3.4B | $3.3B | $3.7B | $3.5B |
| Net property, plant and equipment | $8.5B | $8.5B | $9.2B | $9.3B |
| Investments | $1.1B | $1.0B | $914.0M | $890.4M |
| Other assets | $707.6M | $636.6M | $736.3M | $737.6M |
| Goodwill | $1.5B | $1.5B | $1.5B | $1.7B |
| Other intangibles, net of amortization | $202.1M | $207.6M | $229.9M | $234.9M |
| Noncurrent assets held for sale | $0 | $0 | — | — |
| Total assets | $15.9B | $15.1B | $17.1B | $17.3B |
| Accounts payable | $1.1B | $933.8M | $903.2M | $858.8M |
| Accrued expenses | $507.6M | $452.9M | $500.9M | $414.9M |
| Current portion of long-term debt | $74.7M | $74.6M | $445.4M | $444.9M |
| Dividends payable | $61.5M | $61.5M | $61.3M | $61.3M |
| Income taxes payable | $131.7M | $53.1M | $93.1M | $169.9M |
| Current liabilities held for sale | $0 | $0 | — | — |
| Total current liabilities | $1.9B | $1.6B | $2.0B | $1.9B |
| Long-term debt | $1.8B | $1.8B | $3.2B | $3.2B |
| Postretirement benefits | $45.2M | $45.1M | $31.9M | $32.1M |
| Pension benefits | $105.7M | $115.5M | $118.0M | $121.6M |
| Other noncurrent liabilities | $1.2B | $1.1B | $1.1B | $1.1B |
| Deferred income taxes | $368.6M | $369.3M | $407.1M | $366.5M |
| Noncurrent liabilities held for sale | $0 | $0 | — | — |
| Common stock, $.01 par value, authorized – 275,000, issued and outstanding – 117,994 in 2026 and 117,716 in 2025 | $1.2M | $1.2M | $1.2M | $1.2M |
| Mandatory convertible preferred stock, Series A, no par value, $1,000 stated value, authorized – 15,000, issued and outstanding – 2,300 in 2026 and 2025 | $2.2B | $2.2B | $2.2B | $2.2B |
| Additional paid-in capital | $3.0B | $3.0B | $3.0B | $3.0B |
| Accumulated other comprehensive loss | ($243.6M) | ($259.1M) | ($368.6M) | ($364.5M) |
| Retained earnings | $5.2B | $4.8B | $5.1B | $5.4B |
| Total Albemarle Corporation shareholders’ equity | $10.3B | $9.9B | $10.0B | $10.2B |
| Noncontrolling interests | $258.7M | $257.9M | $272.9M | $258.5M |
| Total equity | $10.5B | $10.1B | $10.3B | $10.5B |
| Total liabilities and equity | $15.9B | $15.1B | $17.1B | $17.3B |
| Line item | Dec 31, 2025 · FY | Dec 31, 2024 · FY | Dec 31, 2023 · FY | Dec 31, 2022 · FY |
|---|---|---|---|---|
| Cash and cash equivalents at beginning of year | $1.2B | $889.9M | $1.5B | $439.3M |
| Net (loss) income | ($465.2M) | ($1.1B) | $1.7B | $2.8B |
| Depreciation and amortization | $658.7M | $588.6M | $429.9M | $300.8M |
| Non-cash goodwill impairment charges | $181.1M | — | — | — |
| Non-cash long-lived asset impairment charges | $245.6M | — | — | — |
| Non-cash restructuring and asset write-offs | $0 | $1.0B | — | — |
| Gain on change in interest in properties/sale of business, net | $0 | $0 | ($71.2M) | $8.4M |
| Stock-based compensation and other | $40.3M | $32.1M | $36.5M | $30.5M |
| Equity in net income of unconsolidated investments (net of tax) | ($243.7M) | ($715.4M) | ($1.9B) | ($772.3M) |
| Dividends received from unconsolidated investments and nonmarketable securities | $93.7M | $358.9M | $2.0B | $801.2M |
| Pension and postretirement expense (benefit) | $23.4M | ($5.3M) | ($1.7M) | ($52.3M) |
| Pension and postretirement contributions | ($20.4M) | ($19.4M) | ($17.9M) | ($16.1M) |
| Realized loss on investments in marketable securities | $0 | $33.7M | — | — |
| Unrealized (gain) loss on investments in marketable securities | ($14.1M) | $30.1M | $39.9M | $3.3M |
| Loss on early extinguishment of debt | $7.5M | $0 | $0 | $19.2M |
| Deferred income taxes | $81.2M | ($230.4M) | $100.9M | $93.3M |
| Decrease (increase) in accounts receivable | $47.3M | $555.2M | ($350.7M) | ($786.1M) |
| Decrease (increase) in inventories | $212.4M | $1.6B | ($962.9M) | ($1.6B) |
| Decrease (increase) in other current assets | $4.0M | $245.0M | ($171.9M) | ($104.7M) |
| Increase (decrease) in accounts payable to third parties | $128.1M | ($862.2M) | ($283.4M) | $1.3B |
| (Decrease) increase in accrued expenses and income taxes payable | ($36.8M) | ($140.1M) | $253.5M | ($201.4M) |
| Noncurrent liability changes and other, net | $339.3M | ($107.1M) | ($114.6M) | ($31.4M) |
| Net cash provided by operating activities | $1.3B | $702.1M | $1.3B | $1.9B |
| Acquisitions, net of cash acquired | $0 | $0 | ($426.2M) | ($162.2M) |
| Capital expenditures | ($589.8M) | ($1.7B) | ($2.1B) | ($1.3B) |
| Proceeds from sale of property and equipment | $32.8M | $29.1M | — | — |
| Proceeds from sale from investments | $290.9M | — | — | — |
| Proceeds (payments) from settlement of foreign currency forward contracts, net | $114.2M | — | — | — |
| Sales (purchases) of marketable securities, net | $6.1M | $82.5M | ($204.5M) | $1.9M |
| Investments in equity investments and nonmarketable securities | ($239.0K) | ($270.0K) | ($1.2M) | ($706.0K) |
| Net cash used in investing activities | ($146.0M) | ($1.6B) | ($2.8B) | ($1.4B) |
| Proceeds from issuance of mandatory convertible preferred stock, net of issuance costs | $0 | $2.2B | — | — |
| Proceeds from borrowings of long-term debt and credit agreements | $56.7M | $112.4M | $356.0M | $2.0B |
| Repayments of long-term debt and credit agreements | ($505.7M) | ($112.4M) | ($28.9M) | ($705.0M) |
| Other (repayments) borrowings, net | ($5.7M) | ($631.8M) | $617.0M | ($391.7M) |
| Dividends paid to common shareholders | ($190.5M) | ($188.5M) | ($187.2M) | ($184.4M) |
| Dividends paid to mandatory convertible preferred shareholders | ($166.8M) | ($122.7M) | — | — |
| Dividends paid to noncontrolling interests | ($18.2M) | ($37.2M) | ($105.6M) | ($44.2M) |
| Proceeds from exercise of stock options | $3.2M | $374.0K | $190.0K | $2.8M |
| Withholding taxes paid on stock-based compensation award distributions | ($7.3M) | ($11.9M) | ($27.5M) | ($13.3M) |
| Other | ($55.0K) | ($3.2M) | ($191.0K) | ($6.7M) |
| Net cash (used in) provided by financing activities | ($834.2M) | $1.2B | $623.9M | $611.9M |
| Net effect of foreign exchange on cash and cash equivalents | $123.7M | ($67.0M) | $222.7M | ($37.2M) |
| Increase (decrease) in cash and cash equivalents | $425.8M | $302.3M | ($609.2M) | $1.1B |
| Cash and cash equivalents at end of year | $1.6B | $1.2B | $889.9M | $1.5B |
| Line item | Jun 30, 2026 · YTD | Mar 31, 2026 · Q1 | Sep 30, 2025 · YTD | Jun 30, 2025 · YTD |
|---|---|---|---|---|
| Cash and cash equivalents at beginning of year | $1.6B | $1.6B | $1.2B | $1.2B |
| Net income | $828.2M | $329.0M | ($63.5M) | $84.5M |
| Depreciation and amortization | $313.6M | $157.8M | $495.0M | $330.5M |
| Loss on sale of business | $95.0M | $95.0M | — | — |
| Gain on sale of equity investment | ($42.3M) | ($42.3M) | — | — |
| Stock-based compensation and other | $14.7M | $7.9M | $28.0M | $17.1M |
| Equity in net income of unconsolidated investments (net of tax) | ($247.9M) | ($96.3M) | ($203.2M) | ($142.5M) |
| Dividends received from unconsolidated investments and nonmarketable securities | $131.7M | $0 | $89.0M | $67.8M |
| Pension and postretirement expense | $5.3M | $2.9M | $5.4M | $3.5M |
| Pension and postretirement contributions | ($14.3M) | ($3.2M) | ($15.8M) | ($9.9M) |
| Unrealized (gain) loss on investments in marketable securities | ($2.8M) | $5.1M | ($5.0M) | $5.0M |
| Gain on early extinguishment of debt | ($12.5M) | ($12.6M) | — | — |
| Deferred income taxes | ($19.8M) | ($1.0M) | $10.3M | ($38.9M) |
| Working capital changes | ($53.1M) | ($144.4M) | $46.5M | ($96.8M) |
| Noncurrent liability changes and other, net | $60.4M | $48.3M | $325.9M | $318.0M |
| Net cash provided by operating activities | $1.1B | $346.2M | $893.8M | $538.2M |
| Capital expenditures | ($170.4M) | ($98.7M) | ($434.4M) | ($302.3M) |
| Proceeds from sale of businesses, net of cash sold | $525.2M | $525.2M | — | — |
| Proceeds from sale of property and equipment | $0 | — | $25.7M | $23.8M |
| Proceeds from sale of investments | $123.3M | $123.3M | — | — |
| Proceeds from sale of available for sale debt securities | $0 | — | $288.0M | $288.0M |
| (Payments) proceeds from settlement of foreign currency forward contracts, net | ($18.8M) | ($10.5M) | $144.5M | $171.3M |
| Sales of marketable securities, net | $1.4M | $1.8M | $7.0M | $3.0M |
| Investments in equity investments and nonmarketable securities | ($119.0K) | ($59.0K) | ($180.0K) | ($120.0K) |
| Net cash provided by investing activities | $460.5M | $541.0M | $30.6M | $183.6M |
| Repayments of long-term debt and credit agreements | ($1.3B) | ($1.3B) | ($47.9M) | ($29.1M) |
| Proceeds from borrowings of long-term debt and credit agreements | $36.0M | $18.4M | $38.3M | $19.5M |
| Other debt repayments, net | ($12.3M) | ($11.2M) | ($3.7M) | ($2.4M) |
| Fees related to early extinguishment of debt | ($1.7M) | ($1.6M) | — | — |
| Dividends paid to common shareholders | ($95.4M) | ($47.7M) | ($142.9M) | ($95.2M) |
| Dividends paid to mandatory convertible preferred shareholders | ($83.4M) | ($41.7M) | ($125.1M) | ($83.4M) |
| Dividends paid to noncontrolling interests | ($37.5M) | ($37.5M) | ($18.2M) | ($18.2M) |
| Proceeds from exercise of stock options | $19.6M | $8.9M | $1.5M | $1.2M |
| Withholding taxes paid on stock-based compensation award distributions | ($4.2M) | ($3.9M) | ($3.2M) | ($2.9M) |
| Other | ($438.0K) | ($438.0K) | ($55.0K) | ($55.0K) |
| Net cash used in financing activities | ($1.5B) | ($1.4B) | ($301.2M) | ($210.6M) |
| Net effect of foreign exchange on cash and cash equivalents | ($9.7M) | ($2.0M) | $116.3M | $103.4M |
| Increase in cash and cash equivalents | $13.7M | ($528.2M) | $739.5M | $614.6M |
| Cash and cash equivalents at end of period | $1.6B | $1.1B | $1.9B | $1.8B |
Albemarle Corp score and earnings-call analysis · All covered companies
Figures as reported in SEC filings. General information, not investment advice.